Molecular methods in the diagnosis and management of chronic hepatitis B

Perumal Vivekanandan, Om Vir Singh

Research output: Contribution to journalArticle

Abstract

Chronic hepatitis B (CHB) infection remains a major global problem but the recent advances in molecular methods have revolutionized the diagnosis and management of CHB. Hepatitis B virus (HBV) DNA quantitation is the most useful molecular marker for the diagnosis and management of CHB. There is increasing evidence that the clinical outcome and efficacy of antiviral therapy for CHB could vary with the infecting HBV genotype, core promoter and precore mutations. Early identification of drug resistance is imperative in the management of CHB. The molecular methods for HBV DNA quantitation, HBV genotyping, the identification of mutants, genotypic and phenotypic methods for monitoring drug resistance and their utility and limitations for use in the diagnosis and monitoring of CHB are discussed in this article.

Original languageEnglish (US)
Pages (from-to)921-935
Number of pages15
JournalExpert Review of Molecular Diagnostics
Volume10
Issue number7
DOIs
StatePublished - Jul 2010
Externally publishedYes

Fingerprint

Chronic Hepatitis B
Hepatitis B virus
Drug Resistance
DNA
Antiviral Agents
Genotype
Mutation
Infection

Keywords

  • core promoter mutants
  • drug resistance
  • HBV DNA quantitation
  • HBV genotyping
  • hepatitis B virus
  • molecular methods
  • occult HBV
  • precore mutants

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

Molecular methods in the diagnosis and management of chronic hepatitis B. / Vivekanandan, Perumal; Singh, Om Vir.

In: Expert Review of Molecular Diagnostics, Vol. 10, No. 7, 07.2010, p. 921-935.

Research output: Contribution to journalArticle

Vivekanandan, Perumal ; Singh, Om Vir. / Molecular methods in the diagnosis and management of chronic hepatitis B. In: Expert Review of Molecular Diagnostics. 2010 ; Vol. 10, No. 7. pp. 921-935.
@article{70a140e90b1645d293d0fbb8e8535e71,
title = "Molecular methods in the diagnosis and management of chronic hepatitis B",
abstract = "Chronic hepatitis B (CHB) infection remains a major global problem but the recent advances in molecular methods have revolutionized the diagnosis and management of CHB. Hepatitis B virus (HBV) DNA quantitation is the most useful molecular marker for the diagnosis and management of CHB. There is increasing evidence that the clinical outcome and efficacy of antiviral therapy for CHB could vary with the infecting HBV genotype, core promoter and precore mutations. Early identification of drug resistance is imperative in the management of CHB. The molecular methods for HBV DNA quantitation, HBV genotyping, the identification of mutants, genotypic and phenotypic methods for monitoring drug resistance and their utility and limitations for use in the diagnosis and monitoring of CHB are discussed in this article.",
keywords = "core promoter mutants, drug resistance, HBV DNA quantitation, HBV genotyping, hepatitis B virus, molecular methods, occult HBV, precore mutants",
author = "Perumal Vivekanandan and Singh, {Om Vir}",
year = "2010",
month = "7",
doi = "10.1586/erm.10.75",
language = "English (US)",
volume = "10",
pages = "921--935",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - Molecular methods in the diagnosis and management of chronic hepatitis B

AU - Vivekanandan, Perumal

AU - Singh, Om Vir

PY - 2010/7

Y1 - 2010/7

N2 - Chronic hepatitis B (CHB) infection remains a major global problem but the recent advances in molecular methods have revolutionized the diagnosis and management of CHB. Hepatitis B virus (HBV) DNA quantitation is the most useful molecular marker for the diagnosis and management of CHB. There is increasing evidence that the clinical outcome and efficacy of antiviral therapy for CHB could vary with the infecting HBV genotype, core promoter and precore mutations. Early identification of drug resistance is imperative in the management of CHB. The molecular methods for HBV DNA quantitation, HBV genotyping, the identification of mutants, genotypic and phenotypic methods for monitoring drug resistance and their utility and limitations for use in the diagnosis and monitoring of CHB are discussed in this article.

AB - Chronic hepatitis B (CHB) infection remains a major global problem but the recent advances in molecular methods have revolutionized the diagnosis and management of CHB. Hepatitis B virus (HBV) DNA quantitation is the most useful molecular marker for the diagnosis and management of CHB. There is increasing evidence that the clinical outcome and efficacy of antiviral therapy for CHB could vary with the infecting HBV genotype, core promoter and precore mutations. Early identification of drug resistance is imperative in the management of CHB. The molecular methods for HBV DNA quantitation, HBV genotyping, the identification of mutants, genotypic and phenotypic methods for monitoring drug resistance and their utility and limitations for use in the diagnosis and monitoring of CHB are discussed in this article.

KW - core promoter mutants

KW - drug resistance

KW - HBV DNA quantitation

KW - HBV genotyping

KW - hepatitis B virus

KW - molecular methods

KW - occult HBV

KW - precore mutants

UR - http://www.scopus.com/inward/record.url?scp=79952197555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952197555&partnerID=8YFLogxK

U2 - 10.1586/erm.10.75

DO - 10.1586/erm.10.75

M3 - Article

C2 - 20964611

AN - SCOPUS:79952197555

VL - 10

SP - 921

EP - 935

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 7

ER -